ERBB2 and metastatic malignant neoplasm in the lymph nodes: It is widely known that clinical stages, lymph node metastasis, histological grade, Ki-67 levels, ER, PR, human epidermal growth factor receptor 2 (HER-2) status, and molecular typing are used for the determination of postoperative adjuvant treatment.